9-03-2023, 05:48

MacroGenics Announces Sale of TZIELD™ Royalty Interest for

ROCKVILLE, MD, March 08, 2023 (GLOBE NEWSWIRE) -- MacroGenics, Inc. (Nasdaq: MGNX), a biopharmaceutical company
Globe Newswire9-03-2023, 05:48
8-03-2023, 06:01

MacroGenics Announces Date of Fourth Quarter 2022 Financial

ROCKVILLE, MD, March 07, 2023 (GLOBE NEWSWIRE) -- MacroGenics, Inc. (Nasdaq: MGNX), a biopharmaceutical company
Globe Newswire8-03-2023, 06:01
7-02-2023, 04:59

MacroGenics to Participate in Upcoming Investor

ROCKVILLE, MD, Feb. 06, 2023 (GLOBE NEWSWIRE) -- MacroGenics, Inc. (Nasdaq: MGNX), a biopharmaceutical company focused
Globe Newswire7-02-2023, 04:59